Concurrent chemoradiotherapy versus radiotherapy alone after induction chemoimmunotherapy for stage III NSCLC patients who did not undergo surgery: a single institution retrospective study.

Guan, Song; Ren, Kai; Zhang, Xuyu; Yan, Meng; Li, Xue; Zhao, Lujun

Guan, Song; Ren, Kai; Zhang, Xuyu; Yan, Meng; Li, Xue; Zhao, Lujun.

Affiliation

Guan S; Department of Radiation Oncology, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin, China.
Ren K; Tianjin's Clinical Research Center for Cancer, Tianjin, China.
Zhang X; Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.
Yan M; Department of Radiation Oncology, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin, China.
Li X; Tianjin's Clinical Research Center for Cancer, Tianjin, China.
Zhao L; Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.

Radiat Oncol ; 18(1): 122, 2023 Jul 25.

Article in En | MEDLINE | ID: mdl-37491257

Subject(s)

Carcinoma, Non-Small-Cell Lung; Lung Neoplasms; Humans; Carcinoma, Non-Small-Cell Lung/therapy; Retrospective Studies; Lung Neoplasms/therapy; Neoplasm Staging; Chemoradiotherapy/methods; Immunotherapy

Key words

Concurrent chemoradiotherapy; Immunotherapy; Non-small cell lung cancer

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Radiat Oncol Journal subject: NEOPLASIAS / RADIOTERAPIA Year: 2023 Document type: Article Affiliation country: China

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google